Lantheus to Present at Upcoming Investor Conferences
Lantheus Holdings (NASDAQ: LNTH), a leading radiopharmaceutical company, has announced its participation in three major upcoming investor conferences in February and March 2025. The company's management team will present at:
- B. Riley Securities Precision Oncology & Radiopharma Day in New York (February 28)
- TD Cowen 45th Annual Health Care Conference in Boston (March 4, 2:30 PM ET)
- Leerink Global Healthcare Conference 2025 in Miami (March 11, 1:40 PM ET)
Live webcasts will be available for the TD Cowen and Leerink conferences through the Investors section of Lantheus's website. Replay access will be maintained for at least 30 days following the presentations.
Lantheus Holdings (NASDAQ: LNTH), una delle principali aziende di radiofarmaci, ha annunciato la sua partecipazione a tre importanti conferenze per investitori che si terranno a febbraio e marzo 2025. Il team di gestione dell'azienda presenterà presso:
- B. Riley Securities Precision Oncology & Radiopharma Day a New York (28 febbraio)
- TD Cowen 45a Conferenza Annuale sulla Salute a Boston (4 marzo, 14:30 ET)
- Leerink Global Healthcare Conference 2025 a Miami (11 marzo, 13:40 ET)
Le dirette web saranno disponibili per le conferenze di TD Cowen e Leerink nella sezione Investitori del sito web di Lantheus. L'accesso alle registrazioni sarà mantenuto per almeno 30 giorni dopo le presentazioni.
Lantheus Holdings (NASDAQ: LNTH), una empresa líder en radiofármacos, ha anunciado su participación en tres importantes conferencias de inversores que se llevarán a cabo en febrero y marzo de 2025. El equipo de gestión de la empresa presentará en:
- B. Riley Securities Precision Oncology & Radiopharma Day en Nueva York (28 de febrero)
- TD Cowen 45ª Conferencia Anual de Salud en Boston (4 de marzo, 2:30 PM ET)
- Leerink Global Healthcare Conference 2025 en Miami (11 de marzo, 1:40 PM ET)
Se dispondrá de transmisiones en vivo para las conferencias de TD Cowen y Leerink a través de la sección de Inversores del sitio web de Lantheus. El acceso a las repeticiones se mantendrá durante al menos 30 días después de las presentaciones.
란테우스 홀딩스 (NASDAQ: LNTH), 선도적인 방사성 의약품 회사가 2025년 2월과 3월에 열리는 세 가지 주요 투자자 회의에 참여한다고 발표했습니다. 회사의 경영진은 다음과 같은 자리에서 발표할 예정입니다:
- 뉴욕에서 열리는 B. Riley Securities 정밀 종양학 및 방사성 의약품의 날 (2월 28일)
- 보스턴에서 열리는 TD Cowen 제45회 연례 의료 회의 (3월 4일, 오후 2:30 ET)
- 마이애미에서 열리는 Leerink 글로벌 의료 회의 2025 (3월 11일, 오후 1:40 ET)
TD Cowen 및 Leerink 회의의 라이브 웹캐스트는 란테우스 웹사이트의 투자자 섹션을 통해 제공됩니다. 발표 후 최소 30일 동안 재생 액세스가 유지됩니다.
Lantheus Holdings (NASDAQ: LNTH), une entreprise leader dans le domaine des radio-pharmaceutiques, a annoncé sa participation à trois grandes conférences pour investisseurs prévues en février et mars 2025. L'équipe de direction de l'entreprise présentera lors des événements suivants :
- B. Riley Securities Precision Oncology & Radiopharma Day à New York (28 février)
- TD Cowen 45ème Conférence Annuelle sur la Santé à Boston (4 mars, 14h30 ET)
- Leerink Global Healthcare Conference 2025 à Miami (11 mars, 13h40 ET)
Des webcasts en direct seront disponibles pour les conférences TD Cowen et Leerink via la section Investisseurs du site web de Lantheus. L'accès aux rediffusions sera maintenu pendant au moins 30 jours après les présentations.
Lantheus Holdings (NASDAQ: LNTH), ein führendes Unternehmen im Bereich der Radiopharmazeutika, hat seine Teilnahme an drei wichtigen Investorenkonferenzen im Februar und März 2025 angekündigt. Das Management-Team des Unternehmens wird bei folgenden Veranstaltungen präsentieren:
- B. Riley Securities Precision Oncology & Radiopharma Day in New York (28. Februar)
- TD Cowen 45. Jahreskonferenz für Gesundheitswesen in Boston (4. März, 14:30 Uhr ET)
- Leerink Global Healthcare Conference 2025 in Miami (11. März, 13:40 Uhr ET)
Live-Webcasts werden für die TD Cowen- und Leerink-Konferenzen über den Investorenbereich der Website von Lantheus verfügbar sein. Der Zugriff auf die Wiederholungen bleibt mindestens 30 Tage nach den Präsentationen bestehen.
- None.
- None.
BEDFORD, Mass., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced members of its management team will present at the following upcoming investor conferences.
- B. Riley Securities Precision Oncology & Radiopharma Day in New York on February 28
- TD Cowen 45th Annual Health Care Conference in Boston on March 4 at 2:30 pm ET
- Leerink Global Healthcare Conference 2025 in Miami on March 11 at 1:40 pm ET
A live webcast will be available for the TD Cowen 45th Annual Health Care Conference and Leerink Global Healthcare Conference presentations on the Investors section of the Company’s website at www.lantheus.com. A replay of the webcasts will be available on the Company’s website for at least 30 days following the live presentations.
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
FAQ
When is Lantheus (LNTH) presenting at the TD Cowen Healthcare Conference in 2025?
Which investor conferences is Lantheus (LNTH) attending in February and March 2025?
How long will Lantheus (LNTH) conference webcasts be available for replay?
Which of Lantheus's (LNTH) 2025 conference presentations will have live webcasts?
